Ri Liesner
- Hematology top 0.05%
- Hemophilia Treatment and Research 71
- Blood Coagulation and Thrombosis Mechanisms 48
- Platelet Disorders and Treatments 45
- Genetics top 0.5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 15
- Blood disorders and treatments 8
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
- Nephrology top 1%
- Internal Medicine top 1%
- Immunology top 2%
- Complement system in diseases 10
-
- Cancer-related gene regulation 8
- Co-authors
- Peter W. CollinsKate KhairIan HannC. R. M. HaySamuel J. MachinIan MackieMarie ScullyElizabeth Chalmers
- Cited by
- HematologyGeneticsNephrology
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Ri Liesner
120 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Hematology 5.2k
- Genetics 1.6k
- Nephrology 630
- Internal Medicine 323
- Immunology 1.3k
Countries citing papers authored by Ri Liesner
This map shows the geographic impact of Ri Liesner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ri Liesner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ri Liesner more than expected).
Fields of papers citing papers by Ri Liesner
This network shows the impact of papers produced by Ri Liesner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ri Liesner. The network helps show where Ri Liesner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ri Liesner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 17 | |
| 2 | 2020 | 0 | |
| 3 | 2018 | 12 | |
| 4 | 2018 | 7 | |
| 5 | 2017 | 43 | |
| 6 | 2015 | 34 | |
| 7 | 2014 | 81 | |
| 8 | 2014 | 18 | |
| 9 | Inhibitor eradication therapy in non-severe hemophilia A | 2013 | 1 |
| 10 | 2013 | 6 | |
| 11 | 2011 | 140 | |
| 12 | 2011 | 56 | |
| 13 | 2010 | 38 | |
| 14 | 2008 | 257 | |
| 15 | 2006 | 43 | |
| 16 | 2003 | 9 | |
| 17 | 2003 | 15 | |
| 18 | Mutations in ELA2 encoding for neutrophil elastase are a frequent finding in sporadic but not familial severe congenital neutropenia. | 2000 | 1 |
| 19 | 1999 | 143 | |
| 20 | 1990 | 35 |
About Ri Liesner
Ri Liesner is a scholar working on Hematology, Genetics, Internal Medicine, Nephrology and Immunology, having authored 123 papers that have together received 6.6k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (71 papers), Blood Coagulation and Thrombosis Mechanisms (48 papers), Platelet Disorders and Treatments (45 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers), Complement system in diseases (10 papers), Blood disorders and treatments (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Cancer-related gene regulation (8 papers). The work is most often cited by research in Hematology (5.2k citations), Genetics (1.6k citations), Nephrology (630 citations), Internal Medicine (323 citations) and Immunology (1.3k citations). Ri Liesner has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Peter W. Collins, Kate Khair, Ian Hann, C. R. M. Hay, Samuel J. Machin, Ian Mackie, Marie Scully, Elizabeth Chalmers, David Keeling and Paul Harrison. Their work appears in journals such as Haemophilia, British Journal of Haematology, Blood, Journal of Thrombosis and Haemostasis and Blood Coagulation & Fibrinolysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.